VGTEL, Inc. has entered formal strategic discussions with Bell Rose Capital Inc. regarding the potential acquisition of a next-generation health-technology application developed by 4biddenknowledge Inc., a wholly owned subsidiary of Bell Rose. The health-tech app represents a new class of emerging health technology designed to support users through advanced data-driven insights and an intuitive user experience, though the product has not yet generated sales. Early technical evaluations indicate strong scalability and alignment with VGTL's expanding technology roadmap, according to company statements.
The platform reflects years of innovation inside 4biddenknowledge, whose founder Billy Carson has focused on understanding the deeper connections between knowledge, technology, and human consciousness through his multidisciplinary research spanning ancient civilizations, UAP and extraterrestrial phenomena, and the intersection of science and consciousness. This technology fits directly into VGTL's emerging-tech mandate, said Ken Williams, CEO of VGTEL. He noted meaningful potential not only in the platform itself, but also in the broader perspective Billy Carson brings, particularly his work at the intersection of consciousness, advanced research, and future technologies. Carson has placed significant emphasis on consciousness research, aligning with growing scientific interest in brain activity, perception, and human potential.
Carson expressed readiness to support VGTL's mission if the transaction moves forward, stating he's prepared to serve as an advisor. VGTL is building an ecosystem where emerging technologies can be developed, refined, and deployed at scale, Carson said. Both companies confirmed that negotiations are active and constructive, with due diligence underway and a shared focus on responsible development, scalability, and future commercialization. The discussions reflect VGTL's commitment to identifying early-stage technologies with long-term commercial promise as the company expands into data-driven health technology and emerging consciousness-focused innovation. Updates regarding the potential acquisition will be forthcoming as negotiations progress. For more information about the companies involved, visit https://newsramp.com/newswire/prism.
